Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women: A pilot study

Human Reproduction

Volumn 11, Issue 11, 1996, Pages 2377-2381

  Geisthövel, Franz ^a   Frorath, Brigitte ^a   Brabant, Georg ^b  

^a Inst Gynaecological Endocrinol R   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acarbose; Insulin; PCOD; Testosterone

Indexed keywords

ACARBOSE; GLUCOSE; INSULIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ABDOMINAL DISTENSION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FLATULENCE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PREMENOPAUSE; TESTOSTERONE BLOOD LEVEL;

EID: 0030444899     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019118     Document Type: Article

References (26)

1. Barbieri, R.L., Smith, S. and Ryan, K.J. (1988) The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenemia. Fertil. Steril., 50, 197-212.
2. Chang, R.J., Nakamura, R.M., Judd, H.L. and Kaplan, S.A. (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57, 356-359.
3. De Nobel, E. and van't Laar, A. (1978) The size of the loading dose as an important determinant of the result of the oral glucose tolerance test. Diabetes, 27, 42-48.
4. Evans, D.J., Hoffmann, R.G., Kalkhoff, R.K. and Kissebah, A.M. (1983) Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J. Clin. Endocrinol. Metab., 57, 304-310.
5. Fulghesu, A.M., Lanzone, A., Andreani, C.L. et al. (1995) Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. Fertil Steril., 64, 703-708.
6. Geisthövel, F. (1994) Was ist primär: Insulinresistenz, Hyperandrogenämie, Adipositas, gestörte Pubertät? In Moltz, L. (ed.), Hyperandrogenämie (HA): Schwerpunktfragen aus Diagnostik und Therapie. Deutsche Gesellschaft für Endocrinologie. Merck. Darmstadt, Germany, pp. 29-32.
7. Geisthövel, F., Olbrich, M., Frorath, B. et al. (1994) Obesity and hypertestosteronaemia are independently and synergistically associated with elevated insulin concentrations and dyslipidaemia in pre-menopausal women. Hum. Reprod., 9, 610-616.
8. Givens, J.R., Kurtz, B.R., Kitabchi, A.E. et al. (1987) Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans. J. Clin. Endocrinol. Metab., 64, 377-382.
9. Haffner, S.M., Stern, M.P., Mitchell, B.D. et al. (1990) Incidence of type II diabetes in Mexican Americans predicted in fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes, 39, 283-288.
10. Hansen, B.C., Ortmeyer, H.K. and Bodkin, N.L. (1994) Obesity in the etiology of type 2-diabetes mellitus. International Symposium: New Developments in The Genetics of Type 2-(Non-Insulin-Dependent) Diabetes Mellitus, Wuppertal, FRG, September 26-27.
11. Hirsch, J. and Leibel, R.L. (1991) Clinical review 28: a biological basis for human obesity. J. Clin. Endocrinol. Metab., 73, 1153-1157.
12. Keck, C. and Geisthövel, F. (1994). Long-term FSH-therapy in patients with hypersensitive ovaries. Reprod. Domest. Anim., Suppl. 3, 138.
13. Kim, H., Kadowaki, H., Sakura, H. et al. (1992) Detection of point mutations in the insulin receptor gene in patients with insulin resistance by analysis of single stranded conformation polymorphisms. Diabetologia, 35, 261-266.
14. Krook, A., Kumar, S., Laing, I. et al. (1994) Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes, 43, 357-368.
15. Mertes, G. and Kiep, G. (1996) Untersuchung der Wirksamkeit und Verträglichkeit von Glucobay* (Acarbose) über 2 Jahre im Rahmen einer Anwendungsbeobachtung. Diabetes Stoffwechsel, 5, 169.
16. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039-1057.
17. Nestler, J.E., Barlascini, C.O., Matt, D.W. et al. (1989) Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 68, 1027-1032.
18. Nestler, J.E., Powers, L.P., Matt, D.W. et al. (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metb., 72, 83-89.
19. Plymate, S.R., Matej, L.A., Jones, R.E. and Friedl, K.E. (1988) Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab., 67, 460-464.
20. Prelevic, G.M., Wurzburger, M.I., Balint-Peric, L. and Nesic, J.S. (1990) Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet, 336, 900-903.
21. Reaven, G.M., Bernstein, R., Davis, B. and Olefski, J.M. (1976) Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am. J. Med., 60, 80-88.
22. Sachse, G. (1995) Differentialtherapie mit oralen Antidiabetika. In Allolio, B., Grußendorf, M., Müller, O.A., Olbricht, T. and Schulte, H.M. (eds), 3. Intensivkurs für Klinische Endokrinologie. Bundesdruckerei, Neu-Isenburg, Germany, pp. 216-219.
23. Smith, S., Ravnikar, V.A. and Barbieri, R.L. (1987) Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil. Steril., 48, 72-77.
24. Standl, E. and Vague, P. (1987) Hyperinsulinemia as a possible risk factor of macrovascular disease in diabetes mellitus. Diabète Metab., 13, 279-286.
25. Toeller, M. (1991) Modulation of intestinal glucose absorption: postponement of glucose absorption by alpha-glucosidase inhibitors. In Mogensen, C.E. and Standl, E. (eds), Pharmacology of Diabetes. Walter de Gruyter, Berlin, New York.
26. Velazquez, E.M., Mendoza, S., Hamer, T. et al. (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism, 43, 647-654.